Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Arch Neurol. 2010 Nov;67(11):1350–1356. doi: 10.1001/archneurol.2010.279

Table 3.

Stratified Analyses for rs356219

Na MAF OR (95% CI) p-value
Total PD 1942 0.44 1.41 (1.28–1.55) 1.6 × 10−12
Familial PDb 431 0.44 1.40 (1.20–1.62) 1.5 × 10−5
Sporadic PDc 1511 0.44 1.40 (1.27–1.54) 1.2 × 10−11
Total Controls 2060 0.36 - -

Early-onset PDd 489 0.44 1.37 (1.14–1.63) 5.2 × 10−4
Younger Controlse 591 0.37 - -

Late-onset PDf 1453 0.44 1.41 (1.27–1.56) 2.2 × 10−10
Older Controlsg 1469 0.36 - -

Data presented are for the combined sample in an additive, unadjusted model

a

Fourteen cases and 52 controls failed genotyping for rs356219

b

Patients with at least one first or second-degree relative with PD

c

Patients with no first or second-degree relatives with PD

d

Age at onset ≤ 50 years

e

Random sample of controls selected in proportion to the age at enrollment distribution of early-onset cases

f

Age at onset > 50 years

g

Total controls - younger controls

MAF = minor allele frequency; OR = odds ratio; CI = confidence interval; PD = Parkinson's disease